Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi
- PMID: 2550233
- DOI: 10.1007/BF01968150
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi
Abstract
The in vitro and in vivo activity of the new macrolides azithromycin, clarithromycin and roxythromycin was compared with that of erythromycin against Borrelia burgdorferi. In in vitro tests using ten clinical isolates all macrolides were highly active against Borrelia burgdorferi (MIC90 0.015-0.06 micrograms/ml). Azithromycin was more potent than the other macrolides in experimental animal infection, eradicating the organism in all animals tested at a dosage of 8 mg/kg.
Similar articles
-
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):838-41. doi: 10.1007/BF01967388. Eur J Clin Microbiol Infect Dis. 1990. PMID: 1964899
-
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):131-3. doi: 10.1007/BF01967591. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8388791
-
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.Antimicrob Agents Chemother. 1989 Apr;33(4):591-2. doi: 10.1128/AAC.33.4.591. Antimicrob Agents Chemother. 1989. PMID: 2524998 Free PMC article.
-
Azithromycin and clarithromycin: overview and comparison with erythromycin.Infect Control Hosp Epidemiol. 1992 Jun;13(6):357-68. doi: 10.1086/646545. Infect Control Hosp Epidemiol. 1992. PMID: 1320067 Review.
-
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.Drugs. 1992 Nov;44(5):750-99. doi: 10.2165/00003495-199244050-00007. Drugs. 1992. PMID: 1280567 Review.
Cited by
-
Spectrum of activity of azithromycin.Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):813-20. doi: 10.1007/BF01975833. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1662624 Review.
-
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133. Antimicrob Agents Chemother. 1990. PMID: 2073103 Free PMC article.
-
Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection.Infection. 1992 Nov-Dec;20(6):342-9. doi: 10.1007/BF01710681. Infection. 1992. PMID: 1293055
-
Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.Drugs. 1994 Aug;48(2):297-326. doi: 10.2165/00003495-199448020-00011. Drugs. 1994. PMID: 7527329 Review.
-
In vitro activity of trimethoprim against Borrelia burgdorferi.Eur J Clin Microbiol Infect Dis. 1997 Jun;16(6):458-60. doi: 10.1007/BF02471911. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9248750
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical